Ultimovacs ASA (ULTI.OL)

NOK 2.76

(14.79%)

Total Assets Summary of Ultimovacs ASA

Ultimovacs ASA's latest annual total assets in 2023 was 349.03 Million NOK , down -31.52% from previous year.
Ultimovacs ASA's latest quarterly total assets in 2024 Q2 was 252.81 Million NOK , down -17.82% from previous quarter.
Ultimovacs ASA reported annual total assets of 509.67 Million NOK in 2022, down -22.25% from previous year.
Ultimovacs ASA reported annual total assets of 655.53 Million NOK in 2021, up 23.75% from previous year.
Ultimovacs ASA reported quarterly total assets of 307.61 Million NOK for 2024 Q1, down -11.87% from previous quarter.
Ultimovacs ASA reported quarterly total assets of 387.74 Million NOK for 2023 Q3, down -11.28% from previous quarter.

Annual Total Assets Chart of Ultimovacs ASA (2023 - 2015)

Historical Annual Total Assets of Ultimovacs ASA (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	349.03 Million NOK	-31.52%
2022	509.67 Million NOK	-22.25%
2021	655.53 Million NOK	23.75%
2020	529.71 Million NOK	10.81%
2019	478.04 Million NOK	151.79%
2018	189.86 Million NOK	6.17%
2017	178.82 Million NOK	116.42%
2016	82.62 Million NOK	109.32%
2015	39.47 Million NOK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	252.81 Million NOK	-17.82%
2024 Q1	307.61 Million NOK	-11.87%
2023 Q3	387.74 Million NOK	-11.28%
2023 FY	349.03 Million NOK	-31.52%
2023 Q2	437.05 Million NOK	-11.74%
2023 Q4	349.03 Million NOK	-9.98%
2023 Q1	495.18 Million NOK	-2.84%
2022 Q3	549.59 Million NOK	-5.12%
2022 Q2	579.25 Million NOK	-3.71%
2022 FY	509.67 Million NOK	-22.25%
2022 Q1	601.55 Million NOK	-8.23%
2022 Q4	509.67 Million NOK	-7.26%
2021 Q2	466.49 Million NOK	-5.57%
2021 FY	655.53 Million NOK	23.75%
2021 Q1	494.02 Million NOK	-6.74%
2021 Q4	655.53 Million NOK	53.69%
2021 Q3	426.53 Million NOK	-8.57%
2020 Q4	529.71 Million NOK	-2.51%
2020 Q3	543.32 Million NOK	-5.22%
2020 Q2	573.24 Million NOK	26.46%
2020 FY	529.71 Million NOK	10.81%
2020 Q1	453.29 Million NOK	-5.18%
2019 Q2	521.36 Million NOK	0.0%
2019 Q4	478.04 Million NOK	-2.28%
2019 FY	478.04 Million NOK	151.79%
2019 Q3	489.21 Million NOK	-6.17%
2018 Q3	193.63 Million NOK	26.32%
2018 Q1	166.97 Million NOK	-6.63%
2018 FY	189.86 Million NOK	6.17%
2018 Q2	153.29 Million NOK	-8.19%
2018 Q4	189.86 Million NOK	-1.95%
2017 FY	178.82 Million NOK	116.42%
2017 Q4	178.82 Million NOK	0.0%
2016 FY	82.62 Million NOK	109.32%
2015 FY	39.47 Million NOK	0.0%

Peer Total Assets Comparison of Ultimovacs ASA

Name	Total Assets	Total Assets Difference
Arctic Bioscience AS	300.25 Million NOK	-16.249%
Aqua Bio Technology ASA	34.42 Million NOK	-913.779%
ArcticZymes Technologies ASA	339.32 Million NOK	-2.863%
BerGenBio ASA	174.33 Million NOK	-100.212%
Hofseth BioCare ASA	390.11 Million NOK	10.53%
PCI Biotech Holding ASA	44.05 Million NOK	-692.37%
Thor Medical ASA	330.83 Million NOK	-5.502%